愛爾蘭科克大學(xué)藥學(xué)院2024年招聘博士后職位（智能藥物傳輸技術(shù)）
科克大學(xué)（University College Cork，簡稱UCC），愛爾蘭最頂尖的大學(xué)之一，世界著名研究型學(xué)府。位于愛爾蘭的第二大城市科克市。作為三所女王學(xué)院之一（科克大學(xué)、高威大學(xué)、貝爾法斯特女王大學(xué)），是愛爾蘭最古老的大學(xué)之一，隸屬于愛爾蘭國立大學(xué)。1997年該大學(xué)正式更名為科克大學(xué)。
Post-Doctoral Researcher, School of Pharmacy
University College Cork
Ireland
March 15, 2024
Contact:N/A
Offerd Salary:歐元42,781 - 歐元49,177
Location:N/A
Working address:N/A
Contract Type:1 Year, Fixed-Term
Working Time:Negotigation
Working type:N/A
Ref info:N/A
Post-Doctoral Researcher, School of Pharmacy
1 Year, Fixed-Term, Whole-Time Post
Position Summary
Postdoctoral Researcher positions in RNA-based therapeutics for sepsis (1 yr) - Laboratory for smart drug delivery technologies at the School of Pharmacy, University College Cork, Ireland
We are looking for an exceptionally enthusiastic, creative, and driven Postdoctoral Researcher with a passion for interdisciplinary science and a desire to apply their unique talents to high-impact work aimed at improving human health, to join the laboratory of Dr. Piotr S. Kowalski at the School of Pharmacy at UCC. Dr. Kowalski's research spans multiple disciplines and will allow candidates to develop their skills in a variety of areas, including RNA delivery, polymer synthesis, nanomaterials design, circular RNA engineering and gene therapy.
Project focuses on engineering RNA-based therapeutics for the treatment of sepsis and is supported by a an Emerging Investigator Award for Health (Health Research Board). This project aims to explore the therapeutic potential of RNA molecules (such as short interfering RNAs and messenger RNAs) to treat and prevent multiple organ failure during sepsis. It will also develop new polymers and nano-sized particles to deliver these new class of RNA-based drugs to cells in lungs and kidneys. The candidate will lead the work on developing and evaluation of novel biomaterials and nanocarriers. Successful candidates will work in a cross-disciplinary research team and will interact closely with a group of collaborators supporting this work, comprised of immunologists, vascular biologist and clinical scientists.
· Candidates with a Ph.D. degree in, organic chemistry, polymer chemistry, pharmaceutical sciences, chemical and biomedical engineering, or a related field are highly encouraged to apply
· Experience in one or more of the following areas will be desirable: polymer/lipid synthesis, organic synthesis, RNA delivery, data-driven material design (Quality by design, design of experiments, machine learning), controlled radical polymerization, bioconjugation, nanoparticle formulation and characterisation, and animal work
· Evidence of peer-reviewed publications in international scientific journals
· Prior practical laboratory experience and the capability to work independently
· Strong interpersonal skills and the ability to contribute in a multidisciplinary team setting
· Excellent oral/written communication skills
· Availability to start in Spring 2024 will be an advantage
About Dr. Piotr S. Kowalski (PI): I am a biochemist by training with a passion for interdisciplinary biomedical research and entrepreneurship. I have completed my scientific training in five different countries, including Poland (Jagiellonian University), the Netherlands (Groningen University), and USA (Massachusetts Institute of Technology). I have 12 years of mentoring, teaching, and leadership experience both in academic and industrial settings. My current work resulted in over twenty published research articles, the invention of four patents on drug delivery technologies, and the creation of a Cambridge-based biotech startup. I have recently won a highly prestigious European Research Council (ERC) Starting grant to elucidate the therapeutic potential of the new class of circular RNAs. I am also member of the GENEGUT EU consortium aiming to create first-in-class oral RNA therapyFor more information please refer to:
https: // www. linkedin.com/in/piotr-kowalski-2715957b/ https:// research.ucc.ie/profiles/C019/piotr.kowalski@ucc.ie
About the University College Cork: UCC is a leading Irish university with an international reputation in innovation, and entrepreneurship. It is ranked in the top 2% of universities worldwide based on the quality of its research outputs and peer esteem indicators and was the first University to be named The Sunday Times University of the Year for two consecutive years (2016 and 2017). UCC has a vibrant research community of almost 3,500 postgraduate students and over 250 postdoctoral researchers, across all the major academic disciplines. UCC has active postdoctoral associations and programs that aim to provide support for all aspects of a postdoc's career, including professional development training and everyday work. UCC is the host and partner of leading Irish research centres, including APC Microbiome Ireland SFI Research Centre and Tyndall National Institute providing the access to state-of-the-art research expertise and core facilities. School of Pharmacy was ranked in the top 100 (66th) in the QS World Rankings by Subject in 2022 and is a part of the College of Medicine and Health, a very interactive environment with multidisciplinary academic teams providing plenty of opportunities to network with world-class scientists and clinicians. UCC is an accredited research organisation and as such can form hosting agreements with third country nationals (and non-EEA nationals) for the purpose of conducting research in the University.
Project Title: Engineering RNA-based therapeutics for treatment of sepsis and sepsis induced multiple organ dysfunction syndrome
Post Duration: 1 year
Salary: 歐元42,781 - 歐元49,177p.a. (IUA PD1 Salary Scale)
For an information package including further details of the post see https: // ore.ucc.ie/.
Informal enquiries can be made in confidence to Piotr Kowalski, PhD, School of Pharmacy, Email: piotr.kowalski@ucc.ie. Please include “Postdoc in RNA therapeutics” in the subject line of your email.
Applications must be submitted online via the University College Cork vacancy portal (https: // ore.ucc.ie/). Queries relating to the online application process should be referred to recruitment@ucc.ie, quoting the job-title and project name.
Please include in your application a CV, including contact details of at least two referees, and a cover letter.
Candidates should apply, in confidence, before 12 noon (Irish Local Time) on Friday, the 15th March 2024
No late applications will be accepted.
Please note that an appointment to posts advertised will be dependent on University approval, together with the terms of the employment control framework for the higher education sector.
UCC is committed to creating and fully embracing an inclusive environment where diversity is celebrated. As a University we strive to create a workplace that reflects the diversity of our student population where people from a wide variety of backgrounds learn from one another, share ideas, and work collaboratively. UCC is committed to being an employer that recognises the value of diversity amongst its staff. We encourage applicants to consult our policies at https: // www. ucc.ie/en/edi/policies/ and initiatives at https: // www. ucc.ie/en/edi/implementation/ and we welcome applications from everyone, including those who are underrepresented in the protected characteristics set out in our Equal Opportunities & Diversity Policy.
UNIVERSITY COLLEGE CORK IS AN EQUAL OPPORTUNITIES EMPLOYER
Contact Person : Dr. Piotr Kowalski Contact Email : piotr.kowalski@ucc.ie Job ID : 074931 Contact Number : Close Date : 15-Mar-2024 12:00
